Vontobel Holding
BMRN icon

Vontobel Holding’s BioMarin Pharmaceuticals BMRN Stock Holding History

Vontobel Holding’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$444K Sell
7,764
-3,221
-29% -$176K ﹤0.01% 1093
2026
Q1 		$621K Sell
10,985
-306
-3% -$17.8K ﹤0.01% 777
2025
Q4 		$671K Sell
11,291
-4,708
-29% -$256K ﹤0.01% 895
2025
Q3 		$867K Buy
15,999
+8,098
+102% +$463K ﹤0.01% 768
2025
Q2 		$434K Buy
7,901
+3,202
+68% +$189K ﹤0.01% 943
2025
Q1 		$332K Sell
4,699
-758
-14% -$51K ﹤0.01% 890
2024
Q4 		$359K Sell
5,457
-593
-10% -$39.7K ﹤0.01% 876
2024
Q3 		$425K Buy
6,050
+2,553
+73% +$213K ﹤0.01% 830
2024
Q2 		$288K Sell
3,497
-450
-11% -$37.5K ﹤0.01% 900
2024
Q1 		$345K Sell
3,947
-116
-3% -$10.4K ﹤0.01% 871
2023
Q4 		$392K Sell
4,063
-1,005
-20% -$88.9K ﹤0.01% 859
2023
Q3 		$448K Sell
5,068
-1,915
-27% -$170K ﹤0.01% 802
2023
Q2 		$605K Buy
6,983
+1,065
+18% +$100K 0.01% 742
2023
Q1 		$575K Buy
5,918
+379
+7% +$39.3K 0.01% 742
2022
Q4 		$564K Buy
5,539
+623
+13% +$58.5K 0.01% 725
2022
Q3 		$418K Sell
4,916
-1,561
-24% -$139K ﹤0.01% 766
2022
Q2 		$544K Sell
6,477
-754
-10% -$60K 0.01% 696
2022
Q1 		$563K Sell
7,231
-1,076
-13% -$90K ﹤0.01% 758
2021
Q4 		$739K Buy
8,307
+746
+10% +$61.6K 0.01% 708
2021
Q3 		$584K Sell
7,561
-179
-2% -$14.1K 0.01% 747
2021
Q2 		$646K Buy
7,740
+1,083
+16% +$85.9K 0.01% 697
2021
Q1 		$503K Sell
6,657
-1,263
-16% -$103K ﹤0.01% 672
2020
Q4 		$684K Buy
+7,920
New +$628K ﹤0.01% 596

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vontobel Holding's BMRN Position: Q2 2026 in Review

Vontobel Holding reduced its BioMarin Pharmaceuticals (BMRN) stake by 29% in Q2 2026, selling an estimated $176K and leaving 7,764 shares worth $444K. The position accounts for ﹤0.01% of the portfolio, ranked #1093.

Vontobel Holding first reported a position in BMRN in Q4 2020 and has held it in 23 quarters since. The position peaked at $867K in Q3 2025. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Vontobel Holding held 7,764 shares of BioMarin Pharmaceuticals worth $444K as of Q2 2026.
  • Vontobel Holding sold 3,221 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $176K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1093 holding.
  • Vontobel Holding first reported a position in BioMarin Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Vontobel Holding's BioMarin Pharmaceuticals position peaked at $867K in Q3 2025.
  • 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.